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We studied the impact of an endoluminally placed stented aortic graft on the geometry of 
a surgically created abdominal aortic dilation (AAD) in nonatherosclerotic mongrel dogs. 
Patulous iliac vein patch infrarenal aortoplasty produced a fusiform AAD, doubling the 
aorta diameter. Lumbar and mesenteric aortic tributaries were preserved and no mural 
thrombus formed, AAI)s created in 23 dogs were endoluminally exduded through 
transfemoral placement of a thin-wall Dacron graft 4 _+ 2 months later. Balloon- 
expandable stents were used to anchor each end of the graft to the aorta. The graft was 
crimped radially in its body and longitudinally at its ends to provide longitudinal and radial 
expandability in these respective zones. Serial color duplex, angiography, and direct caliper 
measurements were made. Before graft placement, a 19% +_ 11% diameter growth was 
observed. At graft placement, flow arrest immediately occurred in the space between the 
graft and the AAD intima in all cases. Although microscopic recanalization of the 
thrombus in this space was seen at sacrifice 6 and 12 months later, no macroscopic duplex 
flow was imaged. A 10% _+ 11% reduction in AAD diameter was measured at 6 months 
(p < 0.001), with no fixrther eduction at 12 months. Graft dimensions remained stable. 
No anastomotic leaks developed. AAD growth stopped uring the first year after effective 
endoluminal exclusion in normotensive dogs despite patent side branches (<1.5 mm 
internal diameter) and no mural thrombus at the time of graft placement. Whether 
microscopic recanalization fthe thrombus that forms outside the graft has an impact after 
1 year remains to be seen. (J Vasc Surg 1996;23:819-31.) 
This experiment was initiated after the pioneering 
report by Parodi ct al. I of successful endoluminal 
grafting of abdominal aortic aneurysms (AAAs) with 
stented grafts in patients. In their original animal 
experiments, a portion of the infrarenal aorta was 
replaced with a large Dacron fusiform graft to mimic 
an ancurysm. 2 Mural thrombus formed by the time of 
stented graft placement. The Dacron aneurysm ana- 
log had no side branches. The question arose that if 
lumbar or mesenteric circulation persisted, could an 
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atherosclerotic aneurysm still enlarge even if axial 
lumenal blood flow is diverted by the graft? This 
concern originated from clinical experiences with 
nonresective therapy of AAAs 3-s and has been re- 
ported after endoluminal bypass. 
Another feasibility issue was encountered regard- 
ing deployment. Each graft needed to bc tailor-made 
for each patient on the basis of intricate preoperative 
measurements. Since AAAs are three-dimensional 
tortuous tructures, these measurements were vulner- 
able to error. Limited flexibility to correct for milimc- 
ter variances in diameter and length was one problem 
that could not be addressed by the noncrimped, thin, 
knitted Dacron grafts used. Additionally, graft deliv- 
ery needed to be refined to limit twisting and kinldng 
of the graft during deployment. 
As endoluminal graft applications expand outside 
the AAA arena to trauma nd occlusive disease, these 
issues are being addressed by refinements in devices, 
imaging, and technique. 9q5 
This experiment is the first in a series designed to 
simultaneously look at biologic and technologic issues 
in this evolving field. As a first step we addressed what, 
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if any, importance xists to the side branches that 
eminate from an endoluminally excluded artery. Intu- 
itively, we expected that he space between the graft in 
an endoluminally excluded AAA and the lumenal sur- 
face should thrombose. After all axial flow is diverted, 
the lower-pressure trograde lumbar mesenteric flow 
should have nowhere to go. Flow should cease and 
thrombosis of the entire space should follow, espe- 
cially in the presence of the AAA mural thrombus and 
of the foreign body of the graft. AAA growth should 
then cease. However, if there are large enough 
branches and a significant pressure gradient, flow may 
be maintained into and out of this space. Perhaps re- 
canalization of this thrombus may occur. A pathway 
from the inferior mesenteric artery to a lumbar artery, 
for example, may develop. Is this significant enough 
to encourage further AAA growth? 
Before embarldng on the development of an 
atherosclerotic hypertensive model analogous to hu- 
man beings, we chose to address this issue in a normal 
artery in a normotensive animal. The setting is some- 
what analogous to stented-graft therapy of a trau- 
matic aneurysm in the young patient in which the 
treated artery would have numerous tributaries. Basic 
questions such as does the space thrombose? How fast 
does it thrombose? Can it recanalize? Can the vessel 
continue to enlarge? were addressed. 
With the guidance of Dr. Parodi, Johnson & 
Johnson Interventional Systems Inc. (JJIS) (Warren, 
N.J.) developed a thin, woven Dacron graft that 
addresses many of the deployment concerns we listed. 
It was manufactured to accommodate variances in 
aortic length and diameter and to resist kinldng and 
twisting as it leaves its introducer sheath. The crimp- 
ing that builds in the required memory to accomplish 
this is described. This technical advance is imple- 
mented in this experiment. We evaluated the stability 
of the stented anastomoses, the resistance of the graft 
to dilation, incorporation of the stented graft, the 
concern over extravasation f foreign body, and the 
deployment issues previously referred to. 
MATERIAL AND METHODS 
Twenty-seven young heartworm-free mongrel 
hounds (25 to 30 kg) were evaluated inthe AAALAC- 
approved Biologic Research Laboratory at the Uni- 
versity of Illinois. All animals were treated according 
to the standards set forth in the Guide for the Care and 
use of Laboratory Animals. I6 After a 2-week condi- 
tioning period, each dog underwent surgical creation 
of an abdominal ortic dilation (AAD) by vein patch 
aortoplasty. 
Within 6 months (4 + 2 months), transfemoral 
placement of a stented aortic graft was performed in 
23 dogs. Dogs were killed 6 months later (n = 13) and 
1 year later (n = 7). Three remain alive for long-term 
evaluation. Two killed at 1 year had double-stented 
grafts placed (one inside the other), These two were 
treated to evaluate a method to correct improper 
deployment scenarios. 
Four control dogs Underwent a 2-week condition- 
ing period followed by AAD creation. They were not 
treated with a stented aortic graft and were ldlled at 
6 months. 
Anesthesia. Each dog treated with a stented graft 
was anesthetized in a similar fashion four times during 
the study: at AAD creation, at stented graft place- 
ment, at Duplex follow-up 1 month later, and at 
sacrifice. Each dog was sedated with acepromazine 
(0.05 mg/kg IV) and atropine (0.5 mg/kg IV), 
endotracheally intubated, and placed on a Harvard 
respirator. Thiopental (3 to 5 mg/kg IV) and halo- 
thane (to effect) provided effective anesthesia. Bu- 
prenex (0.05 mg/kg 1M as needed) was used after 
surgery for comfort. Pentobarbital euthanasia solu- 
tion (100 mg/kg IV) was used to kill them. 
Creation of AAD. The abdomen was shaved, 
prepped with betadine, and draped sterily. Kefzol (0.5 
gm IV) was given at the beginning and at the end of 
the procedure. The aorta was exposed through a 
midline laparotomy. The left common iliac vein and 
the infrarenal aorta were mobilized. Heparin (100 
U/kg IV) was given. The 10-mm diameter thin- 
walled iliac vein was harvested and opened longitudi- 
nally to create a patulous vein patch. No adverse 
sequelae of this vein harvest, such as limb swelling, 
occurred. Vascular control of the infrarenal orta was 
obtained, preserving all aortic tributaries. A longitu- 
dinal 4-cm by 2-mm anterior ellipse of aorta was 
excised in lieu of performing a linear aortotomy to 
facilitate the aortoplasty procedure. The aortoplasty 
was completed by sewing the nearly transparent iliac 
vein patch to the aortotomy with continuous 7.0 
Prolene. The procedure lasted 140 + 27 minutes. All 
subjects were ambulatory and tolerated food by 
morning. Estimated blood loss was 0.1 + 0.1 liters. 
Lactated Ringer's IV solution 1.1 + 0.3 liters was 
given. 
Stent graft placement. After induction of general 
endotracheal nesthesia, both groins were shaved, 
prepped with betadine, and draped sterily. Kefzol (0.5 
gm IV) was given at the beginning and at the end of 
the procedure. A radiopaque ruler was positioned 
posteriorly parallel and to the left of the spine. The left 
femoral artery was exposed. A 30-cm long 14F 
introducer sheath (Meditech, Boston Scientific, 
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Waltham, Mass.) containing a hemostatic valve was 
introduced into the femoral artery by the Seldinger 
technique. The sheath was advanced to below the 
lowest renal artery, identified by contrast aortography 
with 50% angiovist under C-arm fluoroscopy. By 
using road mapping and the posterior uler, precise 
localization of the proximal and distal necks of the 
AAD and its orientation in the aorta were obtained. 
The imaged field was fixed to avoid parallax errors. 
]]IS supplied the dimensions of the stented graft. 
A 14F metal cylinder guide (JJIS) 15 cm long was 
used to temporarily render the hemostatic valve of the 
14F introducer sheath incompetent, permitting the 
passage of the stented graft mounted on the balloon 
angioplasty catheter into the introducer sheath and up 
into the proximal infrarenal aorta. The sheath was 
then withdrawn to the iliac level, and the balloon was 
inflated to create the proximal anastomosis by ex- 
panding the proximal stent anchored to the graft into 
the aortic wall. The stent was overexpanded 20% 
compared with the aorta diameter. The expanded 
stent measured 1.2_+ 0.2 cm in diameter and 
3.2 + 0.3 cm in length. The location of the proximal 
anastomosis was calculated from the length of the 
graft, the length of the aorta, and the location of the 
AAD. The entire AAD had to be excluded without 
impinging on the renal or iliac orifices. Next, the 
balloon was withdrawn into the body of the graft and 
reinflated with dilute contrast o expand it to its 
maximum diameter. 
A second, shorter stent was to be used to effect he 
distal "anastomosis." Mounted on a second balloon 
angioplasty catheter (Meditech 10 mm × 6 cm bal- 
loon), a catheter exchange was performed over a 
0.03 S-inch guide wire. The radiopague markers at the 
distal aspect of the graft guided the deployment. The 
expanded istal stent measured 1 + 0.9 cm in diam- 
eter and 1.5 + 0.1 cm in length. The catheter and wire 
were removed, and the femoral arteriotomy was 
closed with 7.0 Prolene. The procedure lasted 
92 + 33 minutes. Estimated blood loss was 0.1 _+ 0.2 
liters. 
Two of the dogs ldlled at 1 year were treated with 
two stented grafts. In both, the proximal stent was 
incorrectly deployed to satisfactorily position the graft 
across the entire AAD; in one case it was placed too 
high, in the other too low. In both, a second stented 
graft was then coaxially easily positioned inside the 
first stented graft. 
Description of  graft. The J.JIS stented graft is 
illustrated in Fig. 1. It consists of a Palmaz stent 
attached to one end of a woven Dacron graft. The 
stent is balloon-expandable and is made of 316L 
stainless teel. The diameter of the proximal and the 
distal stented anastomosis  directly determined by 
the size of the balloon deploying the stent. The graft 
is constructed from type 56 textured Dacron yarn in 
a plain weave with a wall thickness of 0.115 mm. The 
graft is dumbbell shaped with longitudinal crimps in 
the end zones and circumferential crimps in the center 
zone. The end zones measure 15 mm in length and 
the center zone measures 30 mm in length, with a 
diameter of 10 mm. Two radiopaque markers were 
sutured externally to each end of the graft to assist in 
placement. The radial expandability at the ends and 
the longitudinal expandabilit 3, in the body were built 
into the graft by the crimping technique. 
The graft was delivered to us sewn to a balloon- 
expandable stent and mounted on a 12-mm by 6-cm 
balloon angioplasty catheter (Meditech). It was de- 
livered from the manufacturer aligned in a metal 
cylindrical guide. The graft was furled into a cylindri- 
cal guide (described in the previous section) in the 
manner described by Parodi.17 
Pathologic examination. Grafts were harvested 
from the dogs at 6 months and at 1 year postopera- 
tively. Following general endotracheal anesthesia, 
abdominal duplex scan and fluoroscopic arteriogra- 
phy were performed. The abdomen was opened and 
the aorta dissected out from the scar tissue. In situ 
measurements were made and the animal was then 
euthanized. The aorta was submitted for histologic 
examination after iced 10% formalin fixation. 
Geometric measurements. Measurements are 
illustrated in Fig. 2. Four techniques were used. AAD 
diameters were measured at the largest cross section, 
independent of measurement technique. 
In situ caliper measurements were made at AAD 
creation and just before sacrifice. External caliper 
measurements were made of AAD, aorta, and iliac 
diameters and AAD and aortic lengths. The major 
limitation of caliper in situ data was caused by scar 
tissue at sacrifice. 
Color duplex (Accuson 128 XP) measurements 
were obtained immediately before and after stented 
graft placement, 1 month later, and just before 
sacrifice. Internal and external diameters, areas, pe- 
rimeters, and lengths were obtained. A limitation of 
serial duplex scan data included positioning of the 
cursor consistently from one measurement session to 
the next. Cursor positioning was further complicated 
by the wall thickness and the presence of scar tissue. 
Timing with pulsation was also a variable. For the 
sake of conciseness, the percent changes in duplex 
diameters with time were tabulated as averages ob- 
tained from measurements made in the sagital, 
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Fig. 1. Woven thin-walled Dacron graft prototype. Ends are crimped perpendicular to body to 
allow radial expandability, accommodating aortas of different diameters. Crimping in body 
permits longitudinal extendability o accommodate aortas of different lengths. Proximal stent 
came attached to graft. Both were premounted on balloon angioplasty catheter. Middle picture 
shows low profile ofstented graft assembly after folding it into metal introducer. Top and bottom 
pictures how Palmaz stent before and after inflation. 
transverse anteroposterior, and transverse left-tight 
planes. 
Fluoroscopic angiography wasobtained immedi- 
ately before and after stented graft placement and at 
sacrifice and recorded on videotape. Angiovist 50% 
was used as the contrast agent, injected intra-arteri- 
ally. On playback of the videotape, the radiopaque 
ruler allowed measurement of internal diameters and 
lengths of the AAD, graft, stents, aorta, and iliacs. 
One limitation of this measurement relates to the 
positioning of the ruler relative to the aorta. Because 
the dogs were placed in a concave holding device, we 
were able to position the ruler is as close a plane as 
possible with the aorta in relation to the axis of the 
fluoroscope. Since much of our data are represented 
as a ratio between measurements obtained between 
two time points utilizing the same technique, errors 
inherent in the measurements are partially compen- 
sated for. Other theoretical limitations of our fluoro- 
scopic data included parallax and videotape resolu- 
tion. To reduce these errors, measurements were 
taken as close to the center of the image and/or  to the 
radiopaque ruler as possible. 
A limited number of cut film angiograms were 
done, and measurements were derived from the film 
with calipers in comparison to the radiopaque marker. 
Graft porosity, burst strength, and tensile 
testing. Testing was performed by an independent 
laboratory (Bipore, Inc.; Northvale, N.J.) follow- 
ing the Association for the Advancement of Medi- 
cal Instrumentation protocol) 8Burst strength (psi) 
was measured by placing the graft over a latex 
bladder distended in increments by a pressure 
source. Tensile strength was measured in an Instron 
Model 1011 Universal Testing Instrument. Porosity 
(ml /min /cm 2) was measured as the volume of saline 
collected per unit time across a measured surface 
area. 
Data analysis. Data are expressed as a percent 
change of a dimension with time and reported as 
mean and SD. The number of subjects varies per 
calculation on the basis of  the data that were available. 
Paired t test and the Newman-Keuls multiple com- 
parisons test were used to evaluate the significance of 
the dimensional differences measured between the 
nontreated AAD and the treated AAD at 1, 6, and 12 
months. Comparative valuations were also made 
immediately after stent graft placement to data 1, 6, 
and 12 months later. 
The percent change of a dimension (A~*) be- 
tween two time points is calculated as: 100" 
[(~2/-g~) - 1 ], where ( ~2/~; i  ) is the ratio of the 
value of the dimension ~ at two time points, the 
earlier observation being the denominator. Negative 
percentages represent an interval decrease in that 
dimension. 
The 2~ ~ are then averaged across all subjects in 
the treatment interval to represent the percent change 
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Fig. 2. Measurements obtained. 
in a dimension for all animals tudied in the interval 
A_g* 1 . 
Lastly, for the purposes of summarizing the data 
with all four measurement modalities, aggregate di- 
mensional changes were calculated for each interval. 
First, the A523" obtained from data from each mea- 
surement modality of the.same dimension were aver- 
aged together to calculate a composite percent 
change of that dimension, A-~.. Next, the aggregate 
percent change in a dimension for an interval (A g# i) 
was calculated in a manner similar to A 2>~#~ but by 
using the A ~ values in lieu of the A ~* values. A 293" 1 
reprcsents an estimate of growth or shrinkage of a 
dimension in a given interval after stent graft place- 
ment for all animals in that interval. 
RESULTS 
Baseline dimensions before stented graft place- 
ment are tabulated in Table I. Four pairs of lumbar 
vessels, the inferior mesenteric artery, and several 
smaller tributaries originate from the infrarenal aorta. 
All were preserved. All measured <1.5 mm ID. The 
patch itself encompassed 2.7 + 1 branches. The graft 
overlayed the orifices of 4 + 2 branches. The dogs 
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Table I. Baseline measurements ofinfrarenal aorta and AAD 
Lengths Diameters 
(cm) (cm) 
Infrarenal 
Renal to Patch to 
Aorta Patch patch trifurcation 
Normal 
aorta AAD 
Outer Inner Outer Inner 
In situ caliper 3.4 ± 2 (27) 
Duplex 3.3 ± 2.2 (23) 
Fluoroscopic 11.4£ 1.1 (16) 3.1 ±0.3 (22) 
angiogram 
Cutfilm 11.2±1.3 (7) 3.2±0.5 (7) 
angiogram 
4 .4±i  (27) 3±7 (27) 1±0.1 (27) 
1±0.1 (23) 0.9±0.9 (23) 
1.1 i 0.1 (21) 
1.S ± 0.2 (27) 
2 ± 0.2 (23) 1.9 ± 0.3 (23) 
2.1 ± 0.3 (22) 
1 + 0.1 (9) 2.3_+0.3 (7) 
gained 0.5 + 3 kg between creation of AAD and 
stented graft placement. They gained 1.4 + 2 kg 
between graft placement and death. 
The rate of growth of the untreated AAD was 
variable and is plotted in Fig. 3. Each mark on the 
graph represents an individual animal. 
Proximal aorta dimensional changes are summa- 
rized in Table II. The values in the control column 
represent the percent diameter change between cre- 
ation of the AAD and placement of the stented graft. 
The values in the 1-, 6-, and 12-month columns 
represent the percent diameter change between the 
placement of the stented graft and the follow-up study 
at 1, 6, and 12 months, respectively. 
Immediate thrombosis of the space between the 
stented graft outer surface and the AAD inner surface 
followed deployment in every animal. This was seen 
on the Duplex image immediately after the graft was 
placed. Thrombosis occurred despite residual hep- 
arin. Two weeks after stent graft placement, this 
thrombus appeared grossly identical to that found in 
a pseudoaneurysm cavity seen clinically (data from 
pilot experiments not included in this study). On 
sacrifice at 6 months and at 1 year, this thrombus 
appeared grossly to be of mixed consistency: partly 
firm and partly soft, such as one would see laminating 
an aortic aneurysm clinically. However, histologically, 
microscopic areas of thrombus recanalization identi- 
fied as endothelial-lined spaces containing red cells 
were seen at 6 months and at 1 year. 
AAD duplex and in situ caliper percent changes 
are summarized inTable Ill. Interval comparisons are 
made as in Table 1I. The p values represent compari- 
son between AAD growth before stent graft place- 
ment o AAD growth 1, 6, and 12 months after stent 
graft placement. The stented anastomoses never 
leaked. For this reason, the dimensions of the AAD 
were not discernible by angiography after stented 
graft exclusion. Extravasation of the stent graft out- 
side the aortic wall was never seen. 
In Table IV, aggregate AAD dimensional changes 
(by all measuring modal±ties) were averaged to give a 
composite percent change of each AAD dimension. 
Included are the baseline fluoroscopic and cut film 
angiogram data before stented graft placement. AAD 
growth did not occur after stcnted graft placement. 
Rather, a small but significant decrease in AAD size 
was seen 6 months after stented graft placement, with 
no further significant decrease seen at 1 year. 
Table V tabulates geometric data concerning the 
graft. At sacrifice, the grafts were thoroughly incor- 
porated in fibromuscular tissue ingrowth (Fig. 4). 
Caliper measurements were performed on four grafts 
extricated from the aorta (two at 1 year and two at 6 
months), showing virtually no difference in outer 
diameter compared with the preimplant manufactur- 
er's data. At sacrifice, graft thickness measured 
1.9 + 0.4 mm (n = 18) by duplex, which is greater 
than the preimplant thickness (1.1 mm). This figure 
was attributable to the ingrowth of tissue (pseudoin- 
tima formation). This finding was also observed in the 
angiographic data (diminished luminal diameter). 
There was an angiographic -1 _+ 4 (n = 15) per- 
cent change in graft length (not significant) between 
deployment of the proximal and distal stents. At 6 
months, a 1 + 14 (n = 12) percent change in graft 
length was measured between the stents (not signifi- 
cant). At I year a 4 + 18 (n = 5) percent change in 
graft length was observed (not significant). The 
length of the infrarenal aorta was also relatively 
constant: 11 + i cm (n = 16) to 12 _+ 2 cm (n = 19) 
from stented graft placement to sacrifice. 
The diameters of the right and left iliac arteries 
were iaot significantly different at 6 months and 1 
year despite the trauma to the intima on the left side 
during the tight passage of the introducer sheath at 
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Fig. 3. Graph illustrating percent change in AAD diameter for each animal between creation of 
AAD and intervention. Rate of AAD diameter growth in model is not linear. We attribute this 
partly to maturation of scar tissue forming over time around surgically created AM). 
Table II. Geometric data of proximal aorta 
Percent change in diameter by: 
From AAD creation 
to before stented 
graft 
From placement of stented graft to: 
1 Month 6 Months 22 Months 
Duplex 
In situ caliper 
Cut film angiogram 
Fluoroscopic angiogram 
o + 8 (23) 4.6_+10 (16) -2.7 ± 10 (12) -1.5 + 10 (4) 
-8+27 (12) 4+26 (7) 
9 + 12 (9) 
-7 + 10 (ll) -8 + 17 (5) 
graft placement. No iliac or femoral vessels occluded 
or developed severe stenoses. Mild intimal hyper- 
plasia was seen on the left histologically. The iliac 
diameter measured 6 ± 1 mm in outer diameter. 
Minimal changes (within measurement error) were 
observed in iliac diameters at 6 months and at 1 year 
when compared with their diameters at stented graft 
placement. 
Graft burst strength was measured in three grafts 
before implantation (285 psi, 280 psi, and 265 psi, 
respectively) and in three grafts 6 months after im- 
plantation (275 psi, 280 psi, and 290 psi, respec- 
tively). Graft tensile strength was measured in four 
grafts before implantation (74.71 lbs, 73.42 lbs, 
67.95 lbs, and 62.72 lbs, respectively) and in four 
grafts 6 months after implantation (64.72 lbs, 78.35 
lbs, 57.07 lbs, and 89.92 lbs, respectively). Porosity 
was measured in four grafts before implantation (200 
ml/min/cm 2,190 ml /min /cm 2, 180 ml/min/cm 2,
and 160 ml /min /cm 2, respectively) and 6 months 
after implantation (30 ml/min/cm 2,180 ml /min /  
cm 2, 140 ml /min /cm 2, and 0 ml /min /cm 2, respec- 
tively). No significant difference was observed in 
burst strength and tensile strength before and 6 
months after implantation. A significant decrease in 
porosity was observed and was attributed to tissue 
ingrowth. The variability in porosity likely relates to 
how thoroughly the graft was excised from this tissue 
ingrowth. 
To evaluate slippage of the proximal stent, its 
distance from thc renal orifice to the stent was 
measurcd by angiography. Within the limitations of 
our measuremcnts, his distance was not significantly 
different from graft placement to sacrifice: 4 _+ 10 
(N = 12) percent change at 6 months and a -5 _+ 5 
(N = 3) percent change at 12 months. In a separate 
pilot cxperiment, a thin pseudointima was scen to bc 
already completely covering the struts of the proximal 
stent in two dogs sacrificed at 2 weeks, providing a 
secure anchor. At 6 months and i year, a collagen-rich 
but elastin-poor neointima was seen incorporating 
the entire stent and graft. 
Mild curvature of the graft was seen by angiogram 
at sacrifice in 40% of cases (8 of 20). This curvature 
was seen in three of the subjects at the time of the 
original deployment. This finding was imaged at 
1 month by duplex scan in each instance. Little 
progression was seen at later evaluations. When the 
mild curvature of the graft was observed, itwas within 
the AAD, where the graft had room to gently deform 
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Table II I . Abdominal aortic dilation duplex and in situ caliper dimensions 
From AAD 
creation to before 
Percent change in: stented g~'aft 1 Month 
From placement of stented graft  to: 
6 Months 12 Months 
Duplex 
Diameter 21 _+ 12 (26) 
Length 5 _+ 7 (26) 
In situ caliper 
Diameter 29 -+ 4 (4) 
Length 11 -+ 8 (4) 
8.3 _+ 16 (21)* -3.3 _+ 13 (13)* 0 _+ 17 (6)* 
-7.3 _+ 19 (8)* -18 _+ 12 (13)* -14 _+ 11 (6)* 
-0.1 _+ 16 (13)* 9.3 _+ 18 (7)* 
-18_+9 (13)* -2 i_+8 (7)* 
*p < 0.001. 
Table IV. Abdominal aortic dilation composite data 
From AAD From placement of stented graft to: 
creation to before 
Percent change in: stented graft 1 Month 6 Months 12 Months 
Diameter 19+11 (n=26) 0_+12 (n=18)* -10_+11 (n=13)* -5_+15 (n=7)* 
Length 6_+ 7 (n = 25) 0_+6 (n = 5) -17-+ 12 (n = 13)* -14-+9 (n = 7)* 
*p < 0.001. 
into the early soft thrombus. Mature organized 
thrombus seemed to act more like a cast resisting 
further deformation. The curvature seemed to repre- 
sent redundancy in the length of the graft. Slippage of 
the proximal stent was not observed that could 
account for this finding. Either the grafts were not 
fully deployed to length beforc distal stent placement, 
or some relaxation of the radially crimped portion of 
the Dacron graft occurred in the days after deploy- 
ment. Of note, however, is that the crimps never 
became ffaced. At death, each crimp seemed to be 
well preserved. In fact, each was solidly encased in scar 
tissue. Graft patency was not affected by this curva- 
ture. At death, the grafts were uniformly well sup- 
ported by the mature thrombus that formed between 
the graft and the AAD intima. 
Although ldnldng was avoided in this experiment, 
a 40% stenosis was seen just distal to the proximal stent 
immediately after deployment of one graft. This 40% 
stenosis seemed by intraluminal ultrasound (CVIS 
Corporation; Sunnyvale, Calif.) to be caused by an 
axial misalignment (twist). Twisting was seen in a pilot 
experiment before this series: on death, one of the 
external metal markers had been caught in the orifice 
of an aortic tributary and prevented the graft from 
unfurling properly. At the death of the animal with the 
40% stenosis, there was evidence suggesting that this 
was another instance of the same complication. The 
problem with entrapment of the external metal 
marker has since been solved by a gold stripe being 
applied to the length of  the graft. Otherwise, no 
significant axial misalignment was observed in the 
remaining subjects. The crimps in the body of the 
graft seemed to resist any propensity of the graft to 
ldnk or twist during deployment in this nearly linear 
model. 
No leaking developed around the proximal and 
distal stents. On external inspection of the adventitial 
surface of the aorta at autopsy, the stent struts above 
the graft were visible deep in the vessel wall. The 
diameter of the proximal and distal stents and of the 
aorta in which they were incorporated did not change 
6 months or 1 year after placement. 
DISCUSSION 
Endovascular t eatment of abdominal aortic an- 
eurysms apriori may not necessarily exclude the pos- 
sibility of  persistent aneurysmal enlargement from 
persistent perfusion through lumbar and mesenteric 
vessels into the space between the endovascular g aft 
and the inner surface of the aortic aneurysm. This may 
lead to further aneurysm growth and rupture. Aa~eu- 
rysm models used in previous studies did not fully 
address this concern because the excluded aneurysms, 
usually prosthetic, lacked branches. 
This study helps to begin to address this question 
in a model in which all side branches are left patent, no 
mural thrombus forms before treatment, and normal 
intima exists. Despite this nonthrombogenic environ- 
ment, we have demonstrated that flow arrests in the 
space between the graft and the AAD wall immedi- 
ately after stented graft placement despite residual 
heparin anticoagulation. Additionally, despite retro- 
grade filling of lumbar and mesenteric tributaries up 
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Fig. 4. Illustration of graft incorporation. Steel strut ofstent was gently removed (open circle). 
Note how graft is totally incorporated by ingrowth of tissue. 
to but not into the AAD, and microscopic evidence of 
thrombus recanalization, o further enlargement of
the AAD occurred over a 1-year follow-up period. 
A limitation of this model is the influence that the 
scar tissue that forms at the site of AAD creation has 
on the growth of the AAD it encases. During the 
period of observation, which ranged from 3 to 45 
weeks before stent graft placement, no ruptures 
occurred and the AADs grew an average of 19% _+ 11% 
before graft placement. This growth was nonlinear, as 
illustrated in Fig. 3. 
Three issues in this study prevent extrapolation of 
this data to atherosclerotic larger vessel disease in 
hypertensive elderly patients. First, these dogs were 
normotensive, with mean blood pressure less than 70 
mm Hg. Second, the internal diameters of their aortic 
side branches were typically less than 1.5 mm. Hyper- 
tensive patients with larger branches may be able to 
sustain flow in the space. Third, because of the 
smooth nature of the nonatherosclerotic AAD necks 
in our model and the longitudinally crimped esign of 
the ends of our graft, excellent apposition of the graft 
to the aortic lumenal surface was achievable in each of 
our subjects. There is only one other report of a 
longitudinally crimped graft in the literature. 19 As 
discussed below, whether this may be uniformly 
achievable in atherosclerotic aneurysm necks was not 
tested in this study. 
Extrapolation of our data to stented graft therapy 
of traumatic arterial injury, saccular aneurysms, 
pseudoaneurysms, and atherosclerotic vessels may be 
possible as long as the anastomoses become well 
incorporated, hypertension is controlled, and side 
branches are small. However, extrapolation tostented 
graft herapy ofarteriovenous fi tulae, or of traumatic 
injury in which extravasation from a multibranched 
artery occurs into a cavity (e.g., thorax) should not be 
drawn from our model. In both instances, a low 
resistance pathway exists by which flow outside the 
graft can be potentially maintained. Stented graft 
therapy may, however, facilitate subsequent definitive 
operative therapy of these problems. 
Further data analysis demonstrates the benefit of 
the memory imparted to the grafts by crimping. 
These grafts deployed without ldnks and significant 
twists. This deployment contrasts with our earlier 
pilot dog experiments in which noncrimped grafts 
were used and twisting was seen. This twisting and 
kinldng was also reported by others 2in experiments 
using noncrimped, knitted Dacron grafts in dogs. 
Crimping of the graft is effective in permitting a
uniform, reproducible unfurling of the thin Dacron 
graft used. Although extrapolation to the tortuous 
human arterial anatomy cannot be made from our 
neatly linear aortic model, there is no doubt that the 
crimping technique vastly improves the unfurling of 
the graft. The mild curvature we reported in our 
results may be from the "relaxing" of the crimped 
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Table V. Evaluation of mid-graft dimensions in aorta 
From placement of stented graft to: 
Percent change in: 1 Month 6 Months 12 Months 
Duplex 
Diameter 
Transverse perimeter 
Transverse area 
Cut film angiogram 
Diameter 
Fluoroscope angiogram 
Diameter 
1.8 + 12 (23) -3.2 + 15 (13) 1 + 17 (6) 
-2.7 + 11 (20) -0.3 + 17 (13) 2.5 + 14 (5) 
1.8+27 (18) -11 + 16 (13) 15+ 19 (4) 
-5.5 _+ 14 (9) 
-11+12 (11) -8_+8 (5) 
graft into the AAD space before solidification of the 
encasing thrombus. 
The anastomoses did not leak during follow-up. 
The radial expandability built into the ends of the 
graft by the longitudinal crimps allowed sufficient 
freedom to fully expand the underlying stent o secure 
the graft into the wall. The diameter of the proximal 
and distal stents and the underlying aorta did not 
change with time. Stents were ovcrcxpanded >20% 
into the proximal infrarenal aorta and did not slip. On 
autopsy, the stems were firmly embedded in a thick 
neointima. Microscopically, the stents and graft did 
not penetrate the internal elastic lamina but were 
embedded in a collagen-rich neointima. The thin, 
woven Dacron graft did not significantly enlarge and 
was prevented from doing so by the thick organizing 
thrombus around it. Graft burst strength and tensile 
strength did not change. The favorable decrease in 
porosity was attributed to tissue ingrowth. Double- 
stented grafts in two dogs were effective in treating 
deployment complications; no difference in outcome 
was observed. 
Incorporation of the stented graft was universal in 
this young, healthy dog model. Extrapolation to an 
atherosclerotic aortic aneurysm islimited by the issue 
of incorporation. The fibrous cap on the atheroscle- 
rotic aortic surface and the irregularities from calcifi- 
cation are obstacles to uniform stent apposition to the 
aortic surface. This apposition is necessary for incor- 
poration. Balloon-expandable stems offer a better 
chance of surface apposition compared with self- 
expandable stents. Still, the aortic surface may be so 
significantly diseased that healthy incorporation may 
not be achieveable. Leaks at the proximal aortic 
anastomosis have been reported clinically. They have 
been attributed to poor incorporation and to further 
aortic degeneration, causing aortic enlargement a  the 
stented anastomoses. From our data, these two issues 
may be directly linked: enlargement should be pre- 
ventable by the steel struts if they were fully incorpo- 
rated, like scaffolding. Our experience in normal 
vessels hows no aortic enlargement underlying the 
stent. On the contrary, the fully incorporated stent is 
so thoroughly a part of the aortic wall that further 
aortic enlargement a the stented anastomosis seems 
improbable. Unfortunately, full incorporation may be 
difficult to achieve in an atherosclerotic calcified 
aorta. 
The technology of stented graft placement is 
evolving. 2°-38 Basic questions have risen regarding the 
feasibility of this technology. The data reported herein 
confirm that a properly deployed stented graft is 
effective in treating a dilated artery containing no 
mural thrombus despite patent side branches measur- 
ing < 1.5 cm in diameter in a normotensive animal up 
to 1 year of follow-up. 
We thank our medical students Aftab Patni, Wayne Lue, 
and Max Lee for their hard work. 
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D ISCUSSION 
Dr. Fred N. L i t tooy (Maywood, Ill.). The primary 
question to be answered by those investigating the endo- 
vascular epair of  abdominal aortic aneurysms i the fate of  
the aneurysm wall. That is, will the properly excluded 
abdominal aortic aneurysm wall remain intact or rupture 
with time? Also, what are the difficulties in properly exclud- 
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ing the abdominal ortic aneurysm wall, and how can these 
difficulties be overcome? Past clinical experiences with 
aortic exclusion with extra anatomic or in-line bypass have 
provided some useful information about this. Extraana- 
tomic bypass without aortic ligafion has resulted in late 
rupture rates of 15% to 20%. Conversely, with aortic 
ligation and in-line bypass in well over 300 cases reported 
from Albany, no expansion, rupture, or leakage occurred. 
Eleven patients had persistent flow in the aneurysm sac by 
Doppler exam; six of these eventually thrombosed, and no 
increase in diameter occurred in any of those 11 patients. 
Endovascular repair of abdominal ortic aneurysm presents 
several potential problems in the short- and long-term 
treatment results. Incomplete sealing of the anastomosis 
could allow formation of extraluminal channels or per- 
sistent patency of side branches uch as lumbar, inferior 
mesenteric, or middle sacral arteries that could possibly 
cause expansion of the wall outside the graft. Can intra- 
vascular stents provide long-term attachment of a pros- 
thetic graft to an atherosclerotic wall that is lcnown to 
dilate with aging of the patient? What happens to the 
excluded aortic wall and to the thrombus within it and 
around the graft? There has been some evidence of a 
proliferative response at graft-stent arterial interfaces, and 
this raises the question of stenosis at the anastomosis over 
the long term. Within the aneurysm, radial stretching of 
the graft could also cause continued ilatation of the aortic 
wall. Parodi. who has the greatest experience to date with 
endovascular repair of abdominal aortic aneurysms, has 
noted only one dilatation of a treated aorta. This was 
attributed to improper placement of the distal stent into 
the thrombus instead of the aortic wall. Animal models to 
date have had many limitations in the study of the efficacy 
of endovascular repair of abdominal ortic aneurysm. The 
authors are to be congratulated; their model overcomes 
many of these limitations. They preserved the aortic wall 
and patent side branches and avoided prosthetic material. 
They nicely demonstrated that with the proper placement 
of the endovascular g aft, the excluded aortic wall did not 
dilate or rupture despite patent side branches--even in 
animals monitored up to 1 year. Their animal model did 
not address the inability to mimic the features of the 
diseased aortic wall that is encountered in patients and how 
that may affect the anchoring of the stent into the aortic 
wall to prevent migration when coupled with the dilation 
that occurs with age. Do the authors have any suggestions 
as to how to study this in animals? Also. did you see any 
evidence of a proliferative healing response at the graft- 
stent aortic interface that might lead to stenosis in the long 
term? Recently, Criado et al. have developed an animal 
model that leads to rupture within 6 days if left untreated, 
which would provide evidence of the efficacy of this type 
of experimental treatment. Did you see rupture in any 
of your long-term animals who had no stent placed? 
I think the gauntlet is down that animal and human 
experiences to date have shown no evidence that the 
properly excluded aneurysm wall will rupture. But do 
these stents provide secure long-term attachment to the 
aortic wall, and will the long-term complication rate be 
_<3% that is seen in present-day bdominal ortic aneurysm 
repair? 
Dr. Darwin Eton. The ability for the proximal stent 
to be incorporated in the wall is critical to the success of 
stented graft therapy. Unlike in our healthy vascular 
model, incorporation may not be uniformly achievable in 
the fibrotic calcific neck that we see in atherosclerotic 
patients. 
The neointima that covers the stent and the graft did not 
create a hemodynamically significant stenosis at one year 
follow-up. Little progression i  its thickness was imaged 
between six months and one year. 
Rupture did not occur in our model. The scar forming 
after AAD creation encasing the dilation may have provided 
some resistance to aortic expansion over the one year 
follow-up. 
Endoluminal replacement of the aorta is feasible within 
the limitations described in the paper. Whether the long- 
term complication rate will be as low as standard therapy 
cannot be concluded from this paper. 
A satisfactory atherosclerotic model with which to 
evaluate this technology is lacking. Plenty of data is now 
available clinically, the ultimate model setting. Concerns 
exist as to the "anchor" and "seal" properties of the 
proximal stented atherosclerotic aortic anastemosis. These 
concerns are based on the variability in the incorporation f
the proximal stent into atherosclerotic intimal tissue. Stents, 
however, do offer another opportunity. We have elected to 
separate the "seal" property ofa stented anastomosis from 
the "anchor" property. This would make clinical investiga- 
tion a little safer, and the data obtained easier to digest. This 
is accomplished by placing stents at the distal end of grafts 
and using them to secure the distal anastomosis. We have 
preliminary data in a dog model, whereby we balloon- 
expanded stents o as to secure the distal aorta into the end 
of an aortic tube graft or, conversely, tosecure the tube graft 
into the distal aorta. These stents act primarily as "seals". 
These anastomoses take a couple of minutes to perform. 
The technology has the potential of being able to facilitate 
and accelerate aortoiliac surgery. Other benefits include less 
of a need for dissection i  the pelvis, and we hypothesize a 
diminished potential for pseudoaneurysm formation with 
time, since the native vessel and the graft overlap for at least 
a centimeter and are not simply aligned in end-to-end 
fashion. 
At this time, the technology for total endoluminal 
vascular surgery is in its infancy. I am introducing the 
concept of endoluminally assisted operative aortic surgery 
so that benefits from this technology may be reaped by a 
larger number of patients in the immediate future. My belief 
is that advances insurgery and anesthesia in the past decade 
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have led to uniform improved outcomes from aortic sur- 
gery. Using an anterior extra-peritoneal approach, we have 
limited the ileus and discomfort postoperatively enough 
that the mean discharge time in our last forty patients i five 
days. Similar data is being achieved with the traditional 
retro-peritoneal pproach. We will be hard-pressed to 
improve on these outcomes. However, we expect hat the 
stent technology available today combined with these 
operative approaches will be synergistic in that they 
will facilitate one another. Duration of surgery, blood 
and fluid replacement, and operative dissection may poten- 
tially be reduced. Although discharge mean may not 
change, the standard eviation of that mean may become 
narrower. 
